Following the FDA approval, PFE's Hympavzi becomes the first hemophilia medicine approved in the United States to be ...

The approval of Hympavzi Friday was a dose of good news for Pfizer, which is dealing with research setbacks and a challenge ...

The approval of Hympavzi makes it the first treatment for both hemophilia A and B to be administered through a pre-filled pen ...

HYMPAVZI is the first and only approved anti-tissue factor pathway inhibitor in the US for haemophilia A or B treatment.

Pfizer’s Hympavzi receives US FDA approval to treat adults and adolescents with haemophilia A or B without inhibitors: New York Monday, October 14, 2024, 18:00 Hrs [IST] Pfizer ...

The FDA has approved a new preventive treatment for people with certain types of hemophilia that can reduce bleeding episodes, sometimes down to just a few per year.

Daiichi Sankyo and AstraZeneca's ENHERTU has been conditionally approved by China's NMPA for a specific type of NSCLC.

Inventiva will gain a new chairman following the deal as it presses ahead with a Phase III trial for its lead asset.

One doctor spoke out warning that women may be getting misdiagnosed with a common condition when they may actually be ...

Cancer Research UK hailed the shift as the biggest improvement in cervical cancer treatment in more than 20 years ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Trump and Harris Both Like a Child Tax Credit, but With Different Aims Kamala Harris’s campaign is pushing a version of the credit intended to fight child poverty, while Donald Trump sees the ...